HMGB1 and neoplasm: Compared to the control group, the 15 mg/kg P1 treatment significantly increased the HMGB1 levels in the right tumors (injected tumor), with obvious diffuse positive signals in the extracellular matrix, indicating that P1 significantly increased the release of HMGB1 from tumor cells in vivo (Figure 5G).